Ocuphire Pharma, Inc. (OCUP) Year-over-year earnings per share growth for the last twelve months

OCUP (Ocuphire) - company brandmark

Geopolitical tensions and logistical complexities are hindering global drug trials, which is confirmed by the quarterly EPS gap on the GURU.Markets chart, where the -27.50 level represents the current value. Small molecule patents protect Ocuphire Pharma, Inc. (OCUP) in the race for retinal therapy, while high authority in ophthalmology and a successful drop launch ensure investor loyalty.

ocuphire.com (OCUP) Earnings per share growth in annualized terms for the last twelve months: for the period 07/04/2022 - 10/24/2024

OCUP (ocuphire.com): analytical breakdowns and indicator data

- share price and expert price forecast:
General company analysis:Ocuphire - OCUP
Finished products of Ocuphire Pharma, Inc.

Investors are seeking fundamental benchmarks in the financial statements of Ocuphire Pharma, Inc. (OCUP), analyzing net earnings per share dynamics to determine the market value of assets. The current value of -27.50, reflected in the quarterly EPS history, measures profit growth rates, which is critical for a biopharmaceutical business whose FDA compliance costs directly impact final capitalization efficiency.

Who Ocuphire Pharma, Inc. competes with

Alcon Corp (ALC) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Bausch Health (BLCO)|Year-over-year earnings per share growth for the last twelve months glaukos.com|Apellis Pharmaceuticals (APLS) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth BLTE|OCUL - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth HROW (Harrow Inc)|Year-over-year net earnings per share change for the last twelve months Viridian Corp (VRDN)|LENZ - Year-over-year earnings per share growth for the last twelve months|Oculis - Year-over-year earnings per share growth rate for the last twelve months|EyePoint Pharmaceuticals (EYPT) - Year-over-year earnings per share growth for the last twelve months|Kodiak Sciences Inc (KOD) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months ALDX|KALA: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth IRD|OKYO: Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Adverum Biotechnologies ADVM|Quarterly EPS earnings growth Outlook Pharma OTLK|Clearside Biomedical - Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months NBY|KPRX: Quarterly EPS earnings growth|ALIM - Year-over-year net earnings per share change for the last twelve months|EYEN (Eyenovia) - Quarterly EPS earnings growth|GHSI: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months OPT (Opthea)